Inspire Medical Systems Inc. (INSP)
Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
Novavax Inc (NVAX)
Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Johnson & Johnson (JNJ)
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
Evaxion Biotech A/S (EVAX)
Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
4D Molecular Therapeutics (FDMT)
4DMT Provides Company Update and Anticipated Development Milestones for 2026
Emergent Biosolutions Inc. (EBS)
Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
Brainsway Ltd (BWAY)
BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™
Intellia Therapeutics Inc (NTLA)
Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
TG Therapeutics Inc. (TGTX)
TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Dyne Therapeutics Inc (DYN)
Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference